IDEAS home Printed from https://ideas.repec.org/a/spr/pharme/v40y2022i2d10.1007_s40273-022-01192-0.html
   My bibliography  Save this article

A Value Set for the EQ-5D-Y-3L in the Netherlands

Author

Listed:
  • Bram Roudijk

    (EuroQol Research Foundation)

  • Ayesha Sajjad

    (Erasmus University Rotterdam)

  • Brigitte Essers

    (Maastricht University Medical Center)

  • Stefan Lipman

    (Erasmus University Rotterdam)

  • Peep Stalmeier

    (Radboud University Medical Center)

  • Aureliano Paolo Finch

    (EuroQol Research Foundation)

Abstract

Background and Objective There is increasing interest in preference-accompanied measures of health for paediatric populations. The child-friendly EQ-5D version, EQ-5D-Y-3L, is one such instrument, but the lack of a Dutch value set prevents its use in economic evaluations of healthcare interventions in the Netherlands. This study aims at covering this gap by collecting preferences using a standardised protocol for deriving EQ-5D-Y-3L value sets. Methods Composite time trade-off data were collected using videoconferencing interviews, with each respondent completing ten composite time trade-off tasks. Discrete choice experiment data were collected using an online survey, with respondents each completing 15 paired comparisons. Respondents completed these tasks considering what they prefer for a hypothetical 10-year-old child. Discrete choice experiment data were analysed using a ten-parameter mixed-logit model and anchored to the quality-adjusted life-year scale using the mean observed composite time trade-off values. Results The study collected preferences for 197 respondents using composite time trade-off and for 959 respondents using a discrete choice experiment. The discrete choice experiment sample was representative for the Dutch population in terms of age and sex. The level 3 weight for pain/discomfort was the largest, followed by feeling worried, sad or unhappy, usual activities, mobility and self-care. Health state values ranged between −0.218 and 1. Conclusions This study generated a Dutch value set for the EQ-5D-Y-3L, which can be used for the computation of quality-adjusted life-years for economic evaluations of healthcare interventions in paediatric populations.

Suggested Citation

  • Bram Roudijk & Ayesha Sajjad & Brigitte Essers & Stefan Lipman & Peep Stalmeier & Aureliano Paolo Finch, 2022. "A Value Set for the EQ-5D-Y-3L in the Netherlands," PharmacoEconomics, Springer, vol. 40(2), pages 193-203, December.
    • Handle: RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01192-0
    DOI: 10.1007/s40273-022-01192-0
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40273-022-01192-0
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40273-022-01192-0?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Bram Roudijk & A. Rogier T. Donders & Peep F. M. Stalmeier, 2019. "Cultural Values: Can They Explain Differences in Health Utilities between Countries?," Medical Decision Making, , vol. 39(5), pages 605-616, July.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Zhihao Yang & Jie Jiang & Pei Wang & Xuejing Jin & Jing Wu & Yu Fang & Da Feng & Xiaoyu Xi & Shunping Li & Mingxia Jing & Bin Zheng & Weidong Huang & Nan Luo, 2022. "Estimating an EQ-5D-Y-3L Value Set for China," PharmacoEconomics, Springer, vol. 40(2), pages 147-155, December.
    2. David J. Mott & Nancy J. Devlin & Simone Kreimeier & Richard Norman & Koonal K. Shah & Oliver Rivero-Arias, 2022. "Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L," PharmacoEconomics, Springer, vol. 40(2), pages 129-137, December.
    3. Jonathan L. Nazari & A. Simon Pickard & Ning Yan Gu, 2022. "Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L," PharmacoEconomics, Springer, vol. 40(2), pages 139-146, December.
    4. Nancy Devlin & Bram Roudijk & Rosalie Viney & Elly Stolk, 2022. "EQ-5D-Y-3L Value Sets, Valuation Methods and Conceptual Questions," PharmacoEconomics, Springer, vol. 40(2), pages 123-127, December.
    5. Sarah Dewilde & Bram Roudijk & Nafthali H. Tollenaar & Juan M. Ramos-Goñi, 2022. "An EQ-5D-Y-3L Value Set for Belgium," PharmacoEconomics, Springer, vol. 40(2), pages 169-180, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Agata Łaszewska & Ayesha Sajjad & Jan Busschbach & Judit Simon & Leona Hakkaart-van Roijen, 2022. "Conceptual Framework for Optimised Proxy Value Set Selection Through Supra-National Value Set Development for the EQ-5D Instruments," PharmacoEconomics, Springer, vol. 40(12), pages 1221-1234, December.
    2. Donna Rowen & Clara Mukuria & Emily McDool, 2022. "A Systematic Review of the Methodologies and Modelling Approaches Used to Generate International EQ-5D-5L Value Sets," PharmacoEconomics, Springer, vol. 40(9), pages 863-882, September.
    3. Stefan A. Lipman & Brigitte A. B. Essers & Aureliano P. Finch & Ayesha Sajjad & Peep F. M. Stalmeier & Bram Roudijk, 2022. "In a Child’s Shoes: Composite Time Trade-Off Valuations for EQ-5D-Y-3L with Different Proxy Perspectives," PharmacoEconomics, Springer, vol. 40(2), pages 181-192, December.
    4. Sahar Al Shabasy & Maggie Abbassi & Aureliano Finch & Bram Roudijk & Darrin Baines & Samar Farid, 2022. "The EQ-5D-5L Valuation Study in Egypt," PharmacoEconomics, Springer, vol. 40(4), pages 433-447, April.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01192-0. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.